我們已在上線! 進一步了解
ABPWW

Abpro Holdings Warrant
ABPWW

已下市

ABPWW已於2026年2月19日下市。

 

關於: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

員工: 6

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於ABPWW的最新新聞文章。

價格圖表採用Lightweight Charts™實作